Find out what’s new and what’s next in treatment options for ATTR-CM.
-
-
Upcoming clinical trial will assess nucresiran in ATTR-CM
-
What is Donegal Amy?
-
Patisiran improves the functional capacity of individuals with ATTR-CM, study finds
-
Nerve symptoms in ATTR-CM may signal higher risk of heart complications
-
How to ask for ATTR-CM accommodations at work
-
AI has potential to revolutionize how cardiac amyloidosis is diagnosed, researchers say